(Date:7/2/2009)... YORK, July 2 Tuesday night saw th... concert in Barcelona where U2 kicked off their ne...s. , , (RED)ZONES are prime location areas dir...throughout the U2 tour. The tickets for the (RED)...s portion of the ticket sales going to the Global ...
(Date:7/2/2009)...ate cancer patients who receive brachytherapy and ...re unlikely to have a recurrence at 10 years, acco...national Journal of Radiation Oncology*Biology*Phy...y for Radiation Oncology (ASTRO)., Brachytherapy ... next to a tumor either permanently or temporarily...
(Date:7/2/2009)... YORK, July 2 "If recen...l Jackson,s doctors will face intense scrutiny fro.... The pharmacists who filled Mr. Jackson,s prescri...veryone whose name is associated with any of Jacks...in. , , Mr. Mullin won full federal jury acqu...
(Date:7/2/2009)...t might raise odds for diabetes, asthma later on, ...althDay News) -- Babies delivered by cesarean sect...ells, which might explain why they,re at increased...and asthma later in life, Swedish researchers say....ith increased allergy, diabetes and leukemia risks...
Breaking Medicine News(10 mins):Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 3Health News:DEA Will Play Hardball in Investigating Michael Jackson's Doctors 2Health News:C-Section Stress Could Alter Baby's Immune Cells 2(Date:7/2/2009)..., July 2 Acura Pharmaceu...icals, Inc. (NYSE: KG ) announced today that the...d a Complete Response Letter regarding the New Dru... and niacin, USP) Tablets CII, an immediate releas...evere pain. , , (Logo: http://www.newscom....
(Date:6/30/2009)...wire/ -- If you have been eating Garlic to keep th...ile there is absolutely no scientific evidence tha...raying garlic has plenty of evidence to prove it k... grassy lawns is not as strange as it seems. Mosqu...Inc. is being used successfully by city parks, gol...
(Date:6/30/2009)...- Calixa Therapeutics Inc. today announced the ini...patients with complicated urinary tract infections...halosporin antibiotic with excellent in vitro an...sa , including drug resistant isolates. Calixa is...r serious bacterial infections in hospitalized pat...
(Date:6/29/2009)...patients achieved primary and secondary endpoints ...-- AcelRx Pharmaceuticals, Inc. today announced po...udy evaluating the safety and efficacy of its ARX-...cute post-operative pain in patients requiring opi...placebo, patients receiving ARX-01 Sufentanil Nano...
Breaking Medicine Technology:Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 3Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Investing in personalized medicine will benefit Canada 37021 1NTU seals global partnerships on environmental sciences R 26amp 3BD 7135 1NTU seals global partnerships on environmental sciences R 26amp 3BD 7135 2Las Colinas FREE Community Health Fair Benefiting the Shoh Sohail Family of Irving 37020 1Las Colinas FREE Community Health Fair Benefiting the Shoh Sohail Family of Irving 37020 2Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers 3A JNJ ABT LLY PFE NVS GSK 37016 1Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers 3A JNJ ABT LLY PFE NVS GSK 37016 2...Nuvion Antibody Led to a Sustained Response and Re...ies and Was Adequately,Tolerated in Patients with ... Calif., May 22, 2007 /PRNewswire-FirstCall/ -- Da...eeting this week in,Washington D.C. by Dr. William... (visilizumab), an antibody in development as a,tr...
... TOKYO, May 22, 2007 /PRNewswire-FirstCall/ -- Sos..., today announces the,successful completion of a s... opioid analgesic for the treatment of cancer,brea...I single centre, open-label,single dose, cross-ov...al transmucosal fentanyl citrate lozenge) and vers...
Other Medicine Technology:PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 2PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 3PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 4PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 5Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 2Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 3... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: